Oxytocin, a main breastfeeding hormone, prevents hypertension acquired in utero: A therapeutics preview

Biochim Biophys Acta Gen Subj. 2017 Jan;1861(1 Pt A):3071-3084. doi: 10.1016/j.bbagen.2016.09.020. Epub 2016 Sep 20.

Abstract

Hypertension is a major risk factor for ischemic heart disease and stroke, leading causes of morbidity and death worldwide. Intrauterine growth restriction (IUGR), caused by an excess of glucocorticoid exposure to the fetus, produces an imbalance in oxidative stress altering many biochemical and epigenetic gene transcription processes exposing the fetus and neonate to the 'thrifty' phenotype and pervasive polymorphisms appearance damaging health, cognitive, and behavioral processes in later life. OT is a major regulator of oxidative stress radicals that plays a major role in neonatal maturation of the central nervous system and many peripheral tissues expressing oxytocin/oxytocin-receptor (OT/OTR) system in the early postnatal period. OT and OTR are damaged by IUGR and early stress. This review highlights the fact that hypertension is likely to be a legacy of preterm birth due to IUGR and failure to meet nutritional needs in early infancy when fed formula instead of breastfeeding or human milk.

Keywords: DNA methylation; IUGR; development; hypertension; neuroprotection; oxytocin.

Publication types

  • Review

MeSH terms

  • Animals
  • Base Sequence
  • Breast Feeding*
  • Epigenesis, Genetic
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / genetics
  • Hypertension / prevention & control*
  • Oxytocin / therapeutic use*
  • PPAR gamma / metabolism
  • Phenotype

Substances

  • PPAR gamma
  • Oxytocin